JP2008518976A5 - - Google Patents

Download PDF

Info

Publication number
JP2008518976A5
JP2008518976A5 JP2007539376A JP2007539376A JP2008518976A5 JP 2008518976 A5 JP2008518976 A5 JP 2008518976A5 JP 2007539376 A JP2007539376 A JP 2007539376A JP 2007539376 A JP2007539376 A JP 2007539376A JP 2008518976 A5 JP2008518976 A5 JP 2008518976A5
Authority
JP
Japan
Prior art keywords
glycerin
lecithin
glutathione
glutarate
polysorbate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007539376A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008518976A (ja
JP5112876B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/040308 external-priority patent/WO2006060120A2/en
Publication of JP2008518976A publication Critical patent/JP2008518976A/ja
Publication of JP2008518976A5 publication Critical patent/JP2008518976A5/ja
Application granted granted Critical
Publication of JP5112876B2 publication Critical patent/JP5112876B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007539376A 2004-11-07 2005-11-07 還元型グルタチオン経口投与のためのリポソーム処方物 Expired - Lifetime JP5112876B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US52278504P 2004-11-07 2004-11-07
US60/522,785 2004-11-07
US59499605P 2005-05-25 2005-05-25
US60/594,996 2005-05-25
US59704105P 2005-11-06 2005-11-06
US60/597,041 2005-11-06
PCT/US2005/040308 WO2006060120A2 (en) 2004-11-07 2005-11-07 Liposomal formulation for oral administration of glutathione (reduced)

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012005488A Division JP5571706B2 (ja) 2004-11-07 2012-01-13 還元型グルタチオン経口投与のためのリポソーム処方物

Publications (3)

Publication Number Publication Date
JP2008518976A JP2008518976A (ja) 2008-06-05
JP2008518976A5 true JP2008518976A5 (https=) 2012-09-13
JP5112876B2 JP5112876B2 (ja) 2013-01-09

Family

ID=36565495

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007539376A Expired - Lifetime JP5112876B2 (ja) 2004-11-07 2005-11-07 還元型グルタチオン経口投与のためのリポソーム処方物
JP2012005488A Expired - Fee Related JP5571706B2 (ja) 2004-11-07 2012-01-13 還元型グルタチオン経口投与のためのリポソーム処方物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012005488A Expired - Fee Related JP5571706B2 (ja) 2004-11-07 2012-01-13 還元型グルタチオン経口投与のためのリポソーム処方物

Country Status (7)

Country Link
EP (1) EP1817006B1 (https=)
JP (2) JP5112876B2 (https=)
CA (1) CA2628777C (https=)
ES (1) ES2395555T3 (https=)
IL (1) IL182950A (https=)
PL (1) PL1817006T3 (https=)
WO (1) WO2006060120A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1868572A4 (en) * 2005-03-29 2011-03-09 F Timothy Guilford ADMINISTRATION OF GLUTATHION (REDUCED) ON THE INTRAVENOUS WAY OR CAPSULATED IN A LIPOSOME FOR THE TREATMENT OF TNF ALPHA EFFECTS AND FLUID VIRAL SYMPTOMS
WO2011036557A1 (en) * 2009-09-22 2011-03-31 The University Of British Columbia Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles
WO2011082283A2 (en) * 2009-12-30 2011-07-07 Guilford F Timothy Management of myoclonus with oral liposomal reduced glutathione
WO2012094033A1 (en) 2011-01-05 2012-07-12 Livon Laboratories Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
WO2013103840A1 (en) * 2012-01-05 2013-07-11 Guilford Frederick Timothy Anti-cancer composition and method utilizing 3-bp and liposomal reduced glutathione
WO2013109421A1 (en) * 2012-01-05 2013-07-25 Guilford Frederick Timothy Liposomally encapsulated reduced glutathione for management of cancer and disruption of cancer energy cycles
WO2014070769A1 (en) 2012-10-29 2014-05-08 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
WO2014126594A1 (en) * 2013-02-15 2014-08-21 Guilford Frederick Timothy Treatment of evolving bacterial resistance diseases including klebsiella pneumoniae with liposomally formulated glutathione
TWI589308B (zh) 2014-03-25 2017-07-01 林信湧 一種用於治療帕金森氏症之吸入式醫藥組成物及其備製方法
AU2017362500B2 (en) 2016-11-17 2024-09-26 Renovion, Inc. Treatment of Respiratory Tract Diseases and Infections with Ascorbic Acid Compositions
BR112020009910A2 (pt) 2017-11-17 2020-11-03 Renovion, Inc. composições de ácido ascórbico estáveis e métodos de usar as mesmas
KR102171719B1 (ko) 2018-11-14 2020-10-29 충남대학교산학협력단 경구투여용 글루타치온 함유 프로리포좀, 이를 포함하는 약제학적 조성물 및 이의 제조방법
KR20240131358A (ko) 2022-01-04 2024-08-30 레노비온, 아이엔씨. 글루타치온 염을 포함하는 수용액

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746921A (en) * 1980-09-02 1982-03-17 Green Cross Corp:The Oral preparation of human blood coagulation factor
FR2609393A1 (fr) * 1988-02-23 1988-07-15 Serobiologiques Lab Sa Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques comprenant une substance azotee, notamment aminoacides, oligo- ou polypeptides, proteines, et leurs derives, et composition pharmaceutique ou cosmetique ainsi preparee.
US5238683A (en) * 1989-11-24 1993-08-24 The United States Of America As Represented By The Department Of Health And Human Services Aerosol preparation of glutathione and a method for augmenting glutathione level in lungs
JP3272736B2 (ja) * 1991-01-31 2002-04-08 協和醗酵工業株式会社 リポソーム製剤
IT1257697B (it) * 1992-04-24 1996-02-01 Lifegroup Spa N-acil derivati di aminoalcooli come agenti terapeutici attivi sull'edema neurogenico endoneurale a livello del nervo periferico.
US6764693B1 (en) * 1992-12-11 2004-07-20 Amaox, Ltd. Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants
US5607969A (en) * 1992-12-24 1997-03-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem L-DOPA ethyl ester to treat Parkinson's disease
JPH0859503A (ja) * 1994-08-26 1996-03-05 Teijin Ltd ペプチド・蛋白質性薬物の経口、経粘膜投与用リポソーム製剤
US5500232A (en) * 1994-10-06 1996-03-19 Bristol-Myers Squibb Company Calcium fortified beverages
US5891465A (en) * 1996-05-14 1999-04-06 Biozone Laboratories, Inc. Delivery of biologically active material in a liposomal formulation for administration into the mouth
GB9620504D0 (en) * 1996-10-02 1996-11-20 Boehringer Ingelheim Ltd Compositions
US6369106B1 (en) * 1996-12-26 2002-04-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
DE69739663D1 (de) * 1996-12-31 2009-12-31 Antioxidant Pharmaceuticals Co Pharmazeutische glutathionpräparate und methoden zu dern verabreichung
US6756056B2 (en) * 1997-04-08 2004-06-29 Alan A. Rubin Treatment of Parkinson's disease and related disorders by novel formulations of the combination carbidopa-levodopa
US6470894B2 (en) * 1997-09-19 2002-10-29 Thione International, Inc. Glutathione, green tea, grape seed extract to neutralize tobacco free radicals
US5829449A (en) * 1997-09-19 1998-11-03 Thione International, Inc. Smoking products containing antioxidants
US5994323A (en) * 1997-12-31 1999-11-30 P.N. Gerolymatos S.A. Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
FR2777781B1 (fr) * 1998-04-24 2004-04-09 Rhone Poulenc Rorer Sa Associations riluzole et l-dopa pour le traitement de la maladie de parkinson
US6011067A (en) * 1999-06-11 2000-01-04 Thione International, Inc. Antioxidant composition for the treatment of psoriasis and related diseases
JP3989803B2 (ja) * 2002-09-18 2007-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 食品腐敗菌の増殖抑制方法

Similar Documents

Publication Publication Date Title
JP2008518976A5 (https=)
CA2921937C (en) Dendrimer-resveratrol complex
CA2162299C (fr) Composition pharmaceutique pour l'administration orale de flavonoides
JP2004538303A5 (https=)
IL161290A0 (en) Stable composition comprising particles in a frozen aqueous matrix
JP2013513612A5 (https=)
JP2005522421A5 (https=)
WO2006023591A8 (en) Enhanced oil delivery from structured surfactant formulations
WO2007106555A3 (en) Oral formulations of glycyl-2-methylprolyl-glutamate
WO2007005633A3 (en) Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
JP2013500322A5 (https=)
JP2009503097A5 (https=)
WO2006035157A3 (fr) Composes derives de n- (benzyl) phenylacetamide substitues , preparation et utilisations comme ligands des ppar dans le traitement des dereglements lipidiques et/ou glucidiques
WO2004032975A3 (en) Biphenyls and fluorenes as imaging agents in alzheimer's disease
CN104254249B (zh) 帕唑帕尼制剂
CN103006455A (zh) 一种壳聚糖护齿牙膏的配制
JP2004534791A (ja) 呼気保護マイクロカプセル
WO2004075900A3 (en) Pharmaceutical formulations comprising sodium laurylsulfate as bitterness masking agent
JP4958558B2 (ja) 非ステロイド系抗炎症薬剤を備え、良好な風味を有する経口投与製剤
MY139455A (en) Pharmaceutical composition comprising 5-methyl-2-2'(chloro-6'-fluoroanilino) phenylacetic acid
JP2007500181A5 (https=)
CN110225905B (zh) 用于保护皮肤免受重金属和甲醛影响的组合物
WO2006053882A3 (en) Benzothiazole formulations and use thereof
CN107468672A (zh) 一种西地那非口腔速溶膜剂及其制备方法
BR112013027685A2 (pt) composição oral líquida compreendendo divalproex sódico e processo de preparação do mesmo